Navidea Biopharmaceuticals Announces Second Quarter 2013 Results

Published: Aug 07, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced business highlights and consolidated results for the second quarter ended June 30, 2013.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news